Submissions from 2009
SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation status, Ayad M. Al-Katib, Yuan Sun, Anton Goustin, Asfar Azmi, Ben Chen, Amro Aboukameel, and Ramzi M. Mohammad
Submissions from 2008
Preclinical studies of Apogossypolone: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-XL and Mcl-1 proteins in Follicular Small Cleaved Cell Lymphoma model, Alan A. Arnold, Amro Aboukameel, Jianyong Chen, Dajun Yang, Shaomeng Wang, Ayad Al-Katib, and Ramzi M. Mohammad
Submissions from 2007
Progression of renal cell carcinoma is inhibited by genistein and radiation in an orthotopic model, Gilda G. Hillman, Yu Wang, Mingxin Che, Julian J. Raffoul, Mark Yudelev, Omer Kucuk, and Fazlul H. Sarkar
Submissions from 2006
Increased therapeutic potential of an experimental anti-mitotic inhibitor SB715992 by genistein in PC-3 human prostate cancer cell line, David A. Davis, Sarah H. Sarkar, Maha Hussain, Yiwei Li, and Fazlul H. Sarkar
Genistein inhibits radiation-induced activation of NF-κB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest, Julian J. Raffoul, Yu Wang, Omer Kucuk, Jeffrey D. Forman, Fazlul H. Sarkar, and Gilda G. Hillman